Fundz

LianBio Announces $310 Million Crossover Financing

PUBLIC · LIANYOct 29, 2020

Amount Raised

$310 Million

Round Type

Funding Round

PrincetonBiotechnologyHealthcareHealth Care

Description

LianBio, a Chinese company focused on bringing paradigm-shifting medicines to patients in China and major Asian markets, today announced it has raised $310 million in an oversubscribed crossover financing, following its founding and initial financing provided by Perceptive Advisors.

Quick answer

LianBio raised $310 Million in a Funding Round round, dated October 29, 2020. LianBio is based in Princeton, New Jersey, United States.

How much did LianBio raise?
LianBio raised $310 Million in a Funding Round round on October 29, 2020.
What does LianBio do?
LianBio is a cross-border biotechnology company on a mission to bring transformative medicines to patients in China and other Asian markets.
Where is LianBio based and how big is it?
LianBio is based in Princeton, New Jersey, United States.

Source: Fundz verified event record.

Who else raised in Healthcare and Biotechnology around the same time

Companies in the same sectors as LianBio that raised within 45 days of this round, from Fundz verified event records.

  • Azora Therapeutics, Inc. (DE) raised $296K on November 30, 2020.
  • Adagio Medical raised $43M on November 24, 2020.
  • Insightec raised an undisclosed amount (Funding Round) on November 24, 2020.
  • Imago BioSciences, Inc. raised $80M on November 20, 2020.
  • Elevation Oncology raised $65M on November 18, 2020.
  • AliveCor, Inc. raised $56M on November 18, 2020.

Who to call at LianBio, and when

A new round usually means LianBio is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day LianBio raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at LianBio, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at LianBio. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

LianBio

Location

C/O OGIER GLOBAL (CAYMAN) LIMITED

Princeton, New Jersey, United States

About

LianBio is a cross-border biotechnology company on a mission to bring transformative medicines to patients in China and other Asian markets. Through partnerships with highly innovative biopharmaceutical companies around the world, LianBio is advancing a diversified portfolio of clinically validated product candidates with the potential to drive new standards of care across oncology, ophthalmology, inflammatory disease and respiratory indications. LianBio is establishing an international infrastructure to position the company as a partner of choice with a platform to provide access to China and other Asian markets. For additional information, please visit the company’s website at www.lianbio.com.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment LianBio raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for LianBio's next move

See what Strategic adds

LianBio raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.